Metastatic mediastinal hepatoid adenocarcinoma

BMJ Case Rep. 2024 Apr 9;17(4):e253747. doi: 10.1136/bcr-2022-253747.

Abstract

Hepatoid adenocarcinoma (HAC) of the mediastinum is a rare extrahepatic tumour that pathologically and morphologically resembles hepatocellular carcinoma. Extrahepatic HACs primarily occur in the stomach, ovaries, lung, gallbladder, pancreas and uterus. Patients with mediastinal HAC tend to be male smokers over forty years of age. Clinical symptoms of HAC are non-specific and varied in nature; therefore, diagnosis can be challenging and often delayed. Diagnostic investigations encompass haematological, radiological and histological assessment. Surgical resection is reserved for early-stage patients; however, since diagnosis may be delayed, most patients present with metastatic disease, for which the treatment of choice is platinum-based chemotherapy.

Keywords: cancer intervention; lung cancer (oncology); smoking and tobacco; surgery; surgical oncology.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma* / diagnosis
  • Carcinoma, Hepatocellular* / pathology
  • Female
  • Humans
  • Liver Neoplasms* / pathology
  • Male
  • Mediastinum / diagnostic imaging
  • Mediastinum / pathology
  • Pancreas / pathology